AI Acceleration in Life Sciences and Drug Discovery
OpenAI leaders discuss the deployment of specialized biochemistry models for life sciences. The analysis covers the shift from human to compute bottlenecks, the strategic implementation of differentiated access for biosecurity, and the integration of agentic workflows into wet-lab automation.